Merck's Trading Volume Drops 28.45% to $9.67 Billion Ranking 68th in Stock Market

On May 7, 2025, Merck's trading volume was $9.67 billion, down 28.45% from the previous day, ranking 68th in the day's stock market. Merck (MRK) rose 0.10%.

Merck has announced that it will be conducting a clinical trial for its new drug, which is designed to treat a rare form of cancer. The trial will involve 500 patients and is expected to last for two years. The company has stated that the results of the trial will be crucial in determining the drug's efficacy and safety.

Merck has also announced that it will be expanding its manufacturing capabilities in order to meet the growing demand for its products. The company has stated that it will be investing $500 million in new facilities and equipment, which will create 1,000 new jobs. The expansion is expected to be completed by the end of 2026.

Merck has also announced that it will be acquiring a biotechnology company that specializes in the development of gene therapies. The acquisition is expected to be completed by the end of the year and will allow Merck to expand its portfolio of innovative treatments. The company has stated that the acquisition will be a key part of its strategy to become a leader in the field of gene therapy.